HillSignal

CVRx, Inc.

Total Raised
--
Contracts
--
Patents
--
PAC Giving
--

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).

Form D Funding

No recent SEC Form D filings found.

Market Intelligence & News

Benzinga Aug 7, 2026

CVRx Stock Is Falling Overnight: Here's What's Driving the Move

CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.

Yahoo Aug 6, 2026

CVRx Reports Second Quarter 2026 Financial and Operating Results

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2026. Recent Highlights Total revenue for the second quarter of 2026 was $15.7 million, an increase of approximately 16% over the prior year quarterU.S. revenue

Yahoo May 21, 2026

Humana (HUM) Valuation Check As Barostim Medicare Advantage Coverage Expands For Heart Failure Patients

Humana (HUM) is in focus after CVRx announced that the insurer has issued a Medicare Advantage coverage policy for Barostim therapy, including patients in the expanded BENEFIT-HF heart failure trial. See our latest analysis for Humana. The Barostim coverage decision comes as Humana’s latest share price of US$304.10 sits after a sharp 30 day share price return of 44.58% and a 90 day share price return of 59.63%, while the 1 year total shareholder return of 25.69% contrasts with weaker 3 and 5...

Yahoo May 18, 2026

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.

Congressional Trades in $CVRX

No disclosed congressional trades found in $CVRX.

Insider Trades (Form 4)

BUYCHIEF OPERATING OFFICER

Binkowski Brent

$76,43226,223 shares Aug 14, 2026

Key People

Binkowski Brent

CHIEF OPERATING OFFICER

Insider

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro